LUZ SOTO: Open Payments
NPI 1851948996 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,647 in 110 payments from 35 companies in 2025. Trend: 2023 $2,368 · 2024 $2,366 · 2025 $2,647
Food & beverage: $2,569Education: $78
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $260 |
| Rigel Pharmaceuticals, Inc. | 4 | $242 |
| Janssen Biotech, Inc. | 7 | $231 |
| Novartis Pharmaceuticals Corporation | 14 | $187 |
| Celgene Corporation | 7 | $163 |
| Gilead Sciences, Inc. | 7 | $159 |
| ABBVIE INC. | 3 | $157 |
| E.R. Squibb & Sons, L.L.C. | 6 | $121 |
| Merck Sharp & Dohme LLC | 5 | $114 |
| Incyte Corporation | 4 | $99 |
Products named: TAVALISSE, REBLOZYL, Trodelvy, KEYTRUDA, ERLEADA, VRAYLAR, IBRANCE, KISQALI.
Industry payments across FL — which companies pay providers there.
